Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 THE RENAL EXCRETION OF OXYPURINES.

Literature DB >> 14278178

THE RENAL EXCRETION OF OXYPURINES.

S GOLDFINGER, J R KLINENBERG, J E SEEGMILLER.

Abstract

Entities: Chemical

Keywords: ENZYME INHIBITORS; EXCRETION; GOUT; HYPOXANTHINES; KIDNEY; PHARMACOLOGY; PHYSIOLOGY; PROBENECID; PURINES; PYRIMIDINES; SALICYLATES; SPECTROPHOTOMETRY; SULFINPYRAZONE; URICOSURIC AGENTS; URINE; XANTHINE OXIDASE; XANTHINES

Mesh：

Substances：

Year: 1965 PMID： 14278178 PMCID： PMC292537 DOI： 10.1172/JCI105175

Source DB: PubMed Journal: J Clin Invest ISSN： 0021-9738 Impact factor: 14.808

× No keyword cloud information.

14 in total

1. Study of the paradoxical effects of salicylate in low, intermediate and high dosage on the renal mechanisms for excretion of urate in man.

Authors: T F YU; A B GUTMAN
Journal: J Clin Invest Date: 1959-08 Impact factor: 14.808

2. MUTUAL SUPPRESSION OF THE URICOSURIC EFFECTS OF SULFINPYRAZONE AND SALICYLATE: A STUDY IN INTERACTIONS BETWEEN DRUGS.

Authors: T F YUE; P G DAYTON; A B GUTMAN
Journal: J Clin Invest Date: 1963-08 Impact factor: 14.808

3. Tubular secretion of urate in man.

Authors: A B GUTMAN; T F YU; L BERGER
Journal: J Clin Invest Date: 1959-10 Impact factor: 14.808

4. Uric acid production in gout.

Authors: J E SEEGMILLER; A I GRAYZEL; L LASTER; L LIDDLE
Journal: J Clin Invest Date: 1961-07 Impact factor: 14.808

5. Xanthinuria.

Authors: C J DICKINSON; J M SMELLIE
Journal: Br Med J Date: 1959-12-05

6. The renal excretion of uric acid in patients with gout and in nongouty subjects.

Authors: C A NUGENT; F H TYLER
Journal: J Clin Invest Date: 1959-11 Impact factor: 14.808

7. The enzymatic spectrophotometric method for determination of uric acid.

Authors: L LIDDLE; J E SEEGMILLER; L LASTER
Journal: J Lab Clin Med Date: 1959-12

8. Renal function in gout; with a commentary on the renal regulation of urate excretion, and the role of the kidney in the pathogenesis of gout.

Authors: A B GUTMAN; T F YU
Journal: Am J Med Date: 1957-10 Impact factor: 4.965

9. The renal clearance of alkali-stable inulin.

Authors: M WALSER; D G DAVIDSON; J ORLOFF
Journal: J Clin Invest Date: 1955-10 Impact factor: 14.808

10. THE RENAL CLEARANCE OF ENDOGENOUS "CREATININE" IN MAN.

Authors: J Brod; J H Sirota
Journal: J Clin Invest Date: 1948-09 Impact factor: 14.808

13 in total

1. Nobel lecture in physiology or medicine--1988. The purine path to chemotherapy.

Authors: G B Elion
Journal: In Vitro Cell Dev Biol Date: 1989-04

2. Biochemical studies on the treatment of primary hyperoxaluria.

Authors: D A Gibbs; R W Watts
Journal: Arch Dis Child Date: 1967-10 Impact factor: 3.791

3. Small elevations of glucose concentration redirect and amplify the synthesis of guanosine 5'-triphosphate in rat islets.

Authors: S A Metz; M Meredith; M E Rabaglia; A Kowluru
Journal: J Clin Invest Date: 1993-08 Impact factor: 14.808

THE RENAL EXCRETION OF OXYPURINES.

1. Study of the paradoxical effects of salicylate in low, intermediate and high dosage on the renal mechanisms for excretion of urate in man.

2. MUTUAL SUPPRESSION OF THE URICOSURIC EFFECTS OF SULFINPYRAZONE AND SALICYLATE: A STUDY IN INTERACTIONS BETWEEN DRUGS.

3. Tubular secretion of urate in man.

4. Uric acid production in gout.

5. Xanthinuria.

6. The renal excretion of uric acid in patients with gout and in nongouty subjects.

7. The enzymatic spectrophotometric method for determination of uric acid.

8. Renal function in gout; with a commentary on the renal regulation of urate excretion, and the role of the kidney in the pathogenesis of gout.

9. The renal clearance of alkali-stable inulin.

10. THE RENAL CLEARANCE OF ENDOGENOUS "CREATININE" IN MAN.

1. Nobel lecture in physiology or medicine--1988. The purine path to chemotherapy.

2. Biochemical studies on the treatment of primary hyperoxaluria.

3. Small elevations of glucose concentration redirect and amplify the synthesis of guanosine 5'-triphosphate in rat islets.

Review 4. Molecular variation in relation to purine metabolism.

5. Allopurinol in the treatment of uraemic patients with gout.

6. Adenine formation from adenosine by mycoplasmas: adenosine phosphorylase activity.

7. Uric acid production with particular reference to the role of xanthine oxidase and its inhibition.

8. Allopurinal and acute uric acid nephropathy.

9. Allopurinol in treatment of gout.

10. Current concepts of hyperuricemia and gout.